Home > Insider Trading > Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. (SRPT)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
151 - 160
Next >>

Sarepta Therapeutics Inc (SRPT) Moves Ahead With Seeking Eteplirsen Approval: Hip, Hip, Uh-Oh?

Investors wondered for months if Sarepta Therapeutics Inc (NASDAQ:SRPT) would pursue accelerated approval for Duchenne muscular dystrophy, or DMD, drug eteplirsen.

Keep Reading →

July 25th, 2013 - News

Prosensa Holding BV (RNA), WebMD Health Corp. (WBMD): Three Humongous Health-Care Stocks This Week

If you thought the fireworks ended after the Fourth of July celebrations last week, think again. Plenty of pops and bangs were heard in the world of health-care stocks this week.

Keep Reading →

July 15th, 2013 - News

Sarepta Therapeutics Inc (SRPT): Is The DMD Market Becoming Too Crowded?

A year ago, AVI BioPharma underwent a process from being an $85 million biotechnology company to a $1.3 billion company called Sarepta Therapeutics Inc (NASDAQ:SRPT).

Keep Reading →

July 15th, 2013 - News

YRC Worldwide, Inc. (YRCW), Sarepta Therapeutics Inc (SRPT), Christopher & Banks Corporation (CBK): Russell Rebalance Could Push These Stocks Even Higher!

Last year, these three stocks weren’t even on the radar of most retail investors, but have since returned incredible gains.

Keep Reading →

July 1st, 2013 - News

Sarepta Therapeutics Inc (SRPT), National-Oilwell Varco, Inc. (NOV): Here's What This $17 Billion Hedge Fund Company Has Been Buying

Today, let's look at Viking Global Investors, founded in 1999 by Andreas Halvorsen and David Ott, who had previously worked together at Julian Robertson's respected Tiger Management firm.

Keep Reading →

June 27th, 2013 - Hedge Funds

Sarepta Therapeutics Inc (SRPT), VIVUS, Inc. (VVUS): The Week's Biotech Winner and Loser

The easiest route would involve the companies with the biggest share price movements.

Keep Reading →

June 25th, 2013 - News

Three Views for Sarepta Therapeutics Inc (SRPT) on Prosensa's IPO

Sarepta Therapeutics Inc (NASDAQ:SRPT) won't be the only stock choice for a biotech focusing on Duchenne muscular dystrophy, or DMD, much longer. Its one potential challenger on the scene, Prosensa, ...

Keep Reading →

June 18th, 2013 - News

Clovis Oncology Inc (CLVS), Sarepta Therapeutics Inc (SRPT): Three Healthcare Stocks to Keep an Eye On

The healthcare industry is slowly becoming what the pre-crash technology industry was of the early 2000's.

Keep Reading →

June 18th, 2013 - News

MannKind Corporation (MNKD), Sarepta Therapeutics Inc (SRPT): Why You Shouldn't Buy Stocks in Biotech

How can you double your investment literally overnight? Buy stocks of the right biotech companies. However, you can also cut your investment by half overnight by buying the wrong biotech stocks.

Keep Reading →

June 13th, 2013 - News

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds' portfolio at the end of March. NKTR has experienced a decrease in support from the world's most elite money managers in recent months.

Keep Reading →

June 12th, 2013 - News